Risk factors for the development of interstitial lung disease following severe COVID ... Short-Form 6-Dimension and King's Sarcoidosis Questionnaire in people with sarcoidosis associated fatigue.

Shortly afterward, she was diagnosed with “stage one sarcoidosis on both of her lungs and at the base of her brain, making her lymph nodes swell and making it hard for her to breathe,” People ...

Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized by the formation of noncaseating granulomas, multisystem involvement, intrathoracic (pulmonary and lymph node ...

Sarcoidosis is an inflammatory disease characterized by the formation of granulomas in one or more organs of the body. When left unchecked, chronic inflammation caused by granulomas can lead to ...

Blinded baseline demographics and disease characteristics for ongoing Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis; topline ...

As devastating wildfires and smoke sweep across California, the Foundation for Sarcoidosis Research (FSR) urges individuals to prioritize their immediate and long-term health ...

Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis Further development of namilumab for the treatment of sarcoidosis will be discontinued BASEL, Switzerland and ...

Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis Further development of namilumab for the treatment of sarcoidosis will be discontinued BASEL, Switzerland and LONDON ...

Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis Further development of namilumab for the treatment of sarcoidosis will be discontinued BASEL, Switzerland and ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Interstitial Lung Disease ...